Interleukin-7 and immunorestoration in HIV: Beyond the thymus

Terry J. Fry, Crystal L. Mackall

Research output: Contribution to journalArticle

Abstract

One of the hallmarks of untreated HIV infection is a progressive loss of effective immunity to both HIV-associated and non-HIV antigens. Combination antiretroviral therapy can frequently control viral replication, resulting in variable levels of immune reconstitution, but has not resulted in restoration of effective immunity to the virus. Understanding the limitations of immune reconstitution following highly active antiretroviral therapy (HAART) and identifying approaches to enhance immunity in this context may not only improve outcome for patients with HIV infection but could also provide insight for immune reconstitution in other conditions associated with T cell depletion.

Original languageEnglish (US)
Pages (from-to)803-807
Number of pages5
JournalJournal of Hematotherapy and Stem Cell Research
Volume11
Issue number5
DOIs
StatePublished - Oct 2002
Externally publishedYes

Fingerprint

Interleukin-7
Thymus Gland
Immunity
HIV
HIV Infections
HIV Antigens
Highly Active Antiretroviral Therapy
Viruses
T-Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Interleukin-7 and immunorestoration in HIV : Beyond the thymus. / Fry, Terry J.; Mackall, Crystal L.

In: Journal of Hematotherapy and Stem Cell Research, Vol. 11, No. 5, 10.2002, p. 803-807.

Research output: Contribution to journalArticle

Fry, Terry J. ; Mackall, Crystal L. / Interleukin-7 and immunorestoration in HIV : Beyond the thymus. In: Journal of Hematotherapy and Stem Cell Research. 2002 ; Vol. 11, No. 5. pp. 803-807.
@article{9f8c72c6187e412ead8e76552424e01b,
title = "Interleukin-7 and immunorestoration in HIV: Beyond the thymus",
abstract = "One of the hallmarks of untreated HIV infection is a progressive loss of effective immunity to both HIV-associated and non-HIV antigens. Combination antiretroviral therapy can frequently control viral replication, resulting in variable levels of immune reconstitution, but has not resulted in restoration of effective immunity to the virus. Understanding the limitations of immune reconstitution following highly active antiretroviral therapy (HAART) and identifying approaches to enhance immunity in this context may not only improve outcome for patients with HIV infection but could also provide insight for immune reconstitution in other conditions associated with T cell depletion.",
author = "Fry, {Terry J.} and Mackall, {Crystal L.}",
year = "2002",
month = "10",
doi = "10.1089/152581602760404603",
language = "English (US)",
volume = "11",
pages = "803--807",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Interleukin-7 and immunorestoration in HIV

T2 - Beyond the thymus

AU - Fry, Terry J.

AU - Mackall, Crystal L.

PY - 2002/10

Y1 - 2002/10

N2 - One of the hallmarks of untreated HIV infection is a progressive loss of effective immunity to both HIV-associated and non-HIV antigens. Combination antiretroviral therapy can frequently control viral replication, resulting in variable levels of immune reconstitution, but has not resulted in restoration of effective immunity to the virus. Understanding the limitations of immune reconstitution following highly active antiretroviral therapy (HAART) and identifying approaches to enhance immunity in this context may not only improve outcome for patients with HIV infection but could also provide insight for immune reconstitution in other conditions associated with T cell depletion.

AB - One of the hallmarks of untreated HIV infection is a progressive loss of effective immunity to both HIV-associated and non-HIV antigens. Combination antiretroviral therapy can frequently control viral replication, resulting in variable levels of immune reconstitution, but has not resulted in restoration of effective immunity to the virus. Understanding the limitations of immune reconstitution following highly active antiretroviral therapy (HAART) and identifying approaches to enhance immunity in this context may not only improve outcome for patients with HIV infection but could also provide insight for immune reconstitution in other conditions associated with T cell depletion.

UR - http://www.scopus.com/inward/record.url?scp=0036800897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036800897&partnerID=8YFLogxK

U2 - 10.1089/152581602760404603

DO - 10.1089/152581602760404603

M3 - Article

C2 - 12427286

AN - SCOPUS:0036800897

VL - 11

SP - 803

EP - 807

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 5

ER -